课题基金 / 基金详情

Identification of molecular mechanisms underlying lymphangiogenesis and angiogenesis in tumor progression and metastasis

Identification of molecular mechanisms underlying lymphangiogenesis and angiogenesis in tumor progression and metastasis
鉴定肿瘤进展和转移中淋巴管生成和血管生成的分子机制
批准号:
17014078
负责人:
OIKE Yui chi
金额:
$31.23万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2009

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite intense effort, strategies designed to inhibit tumor cell metastasis have been unsuccessful because of lack of understanding of mechanisms underlying the process. Here we report that increases in expression and secretion of angiopoietin-like protein 2 (Angptl2) by primary tumors are highly correlated with the frequency of tumor metastasis both in patients and in tumor cell-implanted mouse models. Tumor cell-derived Angptl2 accelerates metastasis by activating tumor angiogenesis and lymphangiogenesis. Angptl2 expressed in tumor cells was induced by hypoxia and undernutrition, suggesting that the tumor microenvironment induces a tumor cell-derived Angptl2 signal that promotes metastasis. Conversely, targeted deletion of Angptl2 in tumor cells significantly decreased metastasis in tumor cell-implanted mouse models. Based on the present findings we propose that Angptl2 functions as a key regulator of tumor metastasis. These studies could form the basis of new treatment strategies to antagonize tumor metastasis.
期刊论文(63)
专著(0)
科研奖励(0)
会议论文
Proxl Induces Lympatic Endothelial Differentiation via Integrin a9 and Other Signaling Cascades.
Proxl 通过整合素 a9 和其他信号级联诱导淋巴内皮分化。
DOI: --
发表时间: 2007
期刊: Mol Biol Cell (印刷中)
影响因子: --
作者: [Hidetaka Ohnuki, Hirofumi Inoue, Hironao Nakayama, Shinji Fukuda, Shigeki Higashiyama, Mishima K. et al.]
通讯作者: Mishima K. et al.
アンジオポエチンファミリーとリンパ管・血管;リンパ管・血管標的抗がん療法を目指して (シンポジウム)
血管生成素家族与淋巴管和血管;以淋巴管和血管为靶点的抗癌治疗(研讨会)
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Kuribayashi S, et al., 尾池 雄一]
通讯作者: 尾池 雄一
Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival.
Tie2 受体的缺失会损害胚胎干细胞来源的内皮细胞的存活,但不会损害造血细胞的存活。
DOI: --
发表时间: 2006
期刊: Blood 107
影响因子: --
作者: [Hamaguchi I., Morisada T., Azuma M., Murakami K., Kuramitsu M., Mizukami T., Ohbo K., Yamaguchi K., Oike Y., Dumont DJ., Suda T.]
通讯作者: Suda T.
DOI: 10.1073/pnas.0501902102
发表时间: 2005-09-20
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Kubota, Y, Oike, Y, Suda, T]
通讯作者: Suda, T
41
    国内基金
    海外基金
    基于HIF-1α乳酸化修饰探讨桃红四物汤调控BMSCs-H型血管新生轴促进骨折愈合的分子机制研究
    • 批准号:
      2026JJ80362
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周新
    • 依托单位:
    基于多组学揭示乳酸微环境中SPP1+肺癌细胞和SELE+内皮细胞促进血管新生的机制研究
    • 批准号:
      2026JJ81608
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈双华
    • 依托单位:
    化痰通络汤调控PIEZO1/ACSL4/VEGF轴阻断线粒体机械转导增强内皮细胞铁死亡抗性促缺血性中风后血管新生的机制研究
    手术应激诱导ESM1分泌通过活化内皮细胞HMMR/FAK/SRC/NFκB信号轴促进卵巢癌血管新生的机制研究
    • 批准号:
      2026JJ82422
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      夏丹
    • 依托单位: